News
16hon MSN
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
15h
MedPage Today on MSNIsturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes?Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...
Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...
Less expensive versions of popular weight-loss medications like Wegovy and Zepbound are soon going to be taken off the market ...
An expert has explained that if you take weight-loss drugs you might get 'Ozempic mouth', though it's not all bad.
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...
1d
Health on MSNHospitalizations For Ozempic Side Effects Are Rare—But When Should You Go to the ER?New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results